Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
19.0%
% of XPH's 42 holdings also in SBIO
9.0%
% of SBIO's 89 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
CORCEPT THERAPEUTICS INC | 5.5% | 4.2% | 4.2% |
|
EDGEWISE THERAPEUTICS, INC. | 3.2% | 1.8% | 1.8% |
|
TARSUS PHARMACEUTICALS, INC. | 3.5% | 1.4% | 1.4% |
|
ARVINAS, INC. | 2.2% | 1.0% | 1.0% |
|
NEUMORA THERAPEUTICS, INC. | 0.8% | 1.1% | 0.8% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to SBIO
|
BRISTOL-MYERS SQUIBB CO | 4.3% |
 |
JAZZ PHARMACEUTICALS PLC | 4.3% |
|
INTRA-CELLULAR THERAPIES INC | 4.2% |
|
VIATRIS, INC. | 4.1% |
|
CATALENT INC | 4.0% |
|
PERRIGO CO | 3.7% |
|
AXSOME THERAPEUTICS, INC. | 3.6% |
|
ZOETIS INC | 3.5% |
|
ROYALTY PHARMA PLC CLASS A | 3.4% |
|
JOHNSON & JOHNSON | 3.3% |
XPH Underweight Relative to SBIO
|
ALKERMES PLC | -3.6% |
|
KRYSTAL BIOTECH, INC. | -3.4% |
|
ARCELLX, INC. | -3.2% |
|
CRINETICS PHARMACEUTICALS INC | -3.1% |
|
AVIDITY BIOSCIENCES INC | -2.7% |
|
PTC THERAPEUTICS INC | -2.5% |
|
DENALI THERAPEUTICS INC. | -2.3% |
 |
MERUS N.V. | -2.2% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -2.1% |
|
ACADIA PHARMACEUTICALS INC | -2.1% |